-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
المؤلفون: Gozgit JM; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA. Electronic address: jgozgit@ribontx.com., Vasbinder MM; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Abo RP; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Kunii K; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Kuplast-Barr KG; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Gui B; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Lu AZ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Molina JR; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Minissale E; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Swinger KK; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Wigle TJ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Blackwell DJ; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Majer CR; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Ren Y; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Niepel M; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Varsamis ZA; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Nayak SP; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Bamberg E; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Mo JR; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Church WD; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Mady ASA; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Song J; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Utley L; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Rao PE; Patricia E. Rao Consulting, Acton, MA 01720, USA., Mitchison TJ; Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Warren Alpert 536, Boston, MA 02115, USA., Kuntz KW; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Richon VM; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA., Keilhack H; Ribon Therapeutics, 35 Cambridgepark Drive, Suite 300, Cambridge, MA 02140, USA. Electronic address: hkeilhack@ribontx.com.
المصدر: Cancer cell [Cancer Cell] 2021 Sep 13; Vol. 39 (9), pp. 1214-1226.e10. Date of Electronic Publication: 2021 Jul 22.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
مواضيع طبية MeSH: Drug Resistance, Neoplasm/*drug effects , Interferon Type I/*metabolism , Neoplasms/*drug therapy , Nucleoside Transport Proteins/*genetics , Nucleoside Transport Proteins/*metabolism , Small Molecule Libraries/*administration & dosage, Adaptive Immunity/drug effects ; Animals ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; HEK293 Cells ; HeLa Cells ; Humans ; Mice ; Neoplasms/genetics ; Neoplasms/metabolism ; Signal Transduction/drug effects ; Small Molecule Libraries/pharmacology ; Tumor Escape/drug effects ; Xenograft Model Antitumor Assays
-
9دورية أكاديمية
المؤلفون: Schenkel LB; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; MOMA Therapeutics, Cambridge, MA 02142, USA., Molina JR; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Swinger KK; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; Xilio Therapeutics, Waltham, MA 02451, USA., Abo R; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; Obsidian Therapeutics, Cambridge, MA 02138, USA., Blackwell DJ; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Lu AZ; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Cheung AE; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; A2Empowerment, Arlington, MA 02474, USA., Church WD; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Kunii K; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Kuplast-Barr KG; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Majer CR; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Minissale E; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Mo JR; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Niepel M; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Reik C; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; Bain & Company, Boston, MA 02116, USA., Ren Y; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Vasbinder MM; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Wigle TJ; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Richon VM; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Keilhack H; Department of Biological Sciences, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA., Kuntz KW; Department of Molecular Discovery, Ribon Therapeutics, Inc., Cambridge, MA 02140, USA. Electronic address: kkuntz@ribontx.com.
المصدر: Cell chemical biology [Cell Chem Biol] 2021 Aug 19; Vol. 28 (8), pp. 1158-1168.e13. Date of Electronic Publication: 2021 Mar 10.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Inflammation/*drug therapy , Interleukin-4/*antagonists & inhibitors , Kidney Neoplasms/*drug therapy , Macrophages/*drug effects , Poly(ADP-ribose) Polymerases/*metabolism, Animals ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Dose-Response Relationship, Drug ; Female ; Gene Expression Regulation/drug effects ; Gene Expression Regulation/genetics ; HEK293 Cells ; Humans ; Inflammation/genetics ; Inflammation/metabolism ; Interleukin-4/genetics ; Kidney Neoplasms/genetics ; Kidney Neoplasms/metabolism ; Macrophages/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Models, Molecular ; Molecular Structure ; Poly(ADP-ribose) Polymerases/genetics ; RAW 264.7 Cells ; RNA, Messenger/drug effects ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
-
10دورية أكاديمية
المؤلفون: Wigle TJ; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Ren Y; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Molina JR; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Blackwell DJ; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Schenkel LB; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Swinger KK; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Kuplast-Barr K; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Majer CR; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Church WD; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Lu AZ; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Mo J; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Abo R; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Cheung A; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Dorsey BW; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Niepel M; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Perl NR; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Vasbinder MM; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Keilhack H; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA., Kuntz KW; Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge, MA 02140, USA.
المصدر: Chembiochem : a European journal of chemical biology [Chembiochem] 2021 Jun 15; Vol. 22 (12), pp. 2107-2110. Date of Electronic Publication: 2021 May 04.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 100937360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-7633 (Electronic) Linking ISSN: 14394227 NLM ISO Abbreviation: Chembiochem Subsets: MEDLINE